CBD shows preclinical promise for treating cocaine and methamphetamine addiction through multiple mechanisms
A review of preclinical evidence found CBD reversed cocaine toxicity, reduced motivation to self-administer stimulants, enhanced extinction of drug memories, and prevented relapse in animal models, with several plausible mechanisms identified.
Quick Facts
What This Study Found
CBD reversed cocaine-induced toxicity and seizures, blocked amphetamine behavioral sensitization, reduced cocaine and methamphetamine self-administration, promoted extinction of drug-place associations, and prevented stress- and drug-induced reinstatement. Observational human studies suggest CBD may reduce crack-cocaine withdrawal, craving, impulsivity, and paranoia.
Key Numbers
CBD prevented cocaine seizures and toxicity. Reduced self-administration of cocaine and METH. Enhanced extinction and impaired reconsolidation of cocaine conditioned place preference. Prevented priming-induced reinstatement of METH seeking. Observational data: reduced craving, impulsivity, paranoia.
How They Did This
Review of preclinical and limited human research on CBD effects on cocaine and methamphetamine use disorders, plus analysis of potential mechanisms including neuroadaptation prevention, drug memory erasure, cognitive restoration, and mental health comorbidity treatment.
Why This Research Matters
There are currently no approved medications for cocaine or methamphetamine addiction. If CBD can reduce relapse and craving through the multiple mechanisms identified, it could fill a critical gap in addiction treatment.
The Bigger Picture
The breadth of CBD effects on stimulant addiction, from toxicity protection to relapse prevention, suggests it may act on fundamental addiction processes rather than a single pathway. This multi-target profile could be uniquely suited to the complexity of addiction.
What This Study Doesn't Tell Us
Most evidence is preclinical. Observational human data is preliminary. CBD doses used in animal studies may not translate to humans. The specific mechanisms remain hypothetical. No completed randomized controlled trials in humans.
Questions This Raises
- ?Will CBD show efficacy in randomized human trials for stimulant addiction?
- ?What is the optimal dose and duration of CBD treatment?
- ?Could CBD be combined with behavioral therapies for additive effects?
Trust & Context
- Key Stat:
- No approved stimulant addiction meds
- Evidence Grade:
- Rated preliminary because the evidence is predominantly preclinical, with only observational human data available.
- Study Age:
- Published in 2019. Clinical trials of CBD for stimulant addiction may have progressed since.
- Original Title:
- Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms.
- Published In:
- Molecules (Basel, Switzerland), 24(14) (2019)
- Authors:
- Calpe-López, Claudia(2), García-Pardo, M Pilar, Aguilar, Maria A
- Database ID:
- RTHC-01970
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Could CBD help treat cocaine or meth addiction?
Animal studies show promising results including reduced drug-seeking and relapse prevention. Limited human observations suggest reduced craving and withdrawal. But no randomized controlled trials have been completed yet.
How might CBD work for stimulant addiction?
Multiple mechanisms are proposed: preventing drug-induced brain changes, erasing drug-associated memories, restoring cognitive function, and treating coexisting mental health conditions that drive substance use.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-01970APA
Calpe-López, Claudia; García-Pardo, M Pilar; Aguilar, Maria A. (2019). Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms.. Molecules (Basel, Switzerland), 24(14). https://doi.org/10.3390/molecules24142583
MLA
Calpe-López, Claudia, et al. "Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms.." Molecules (Basel, 2019. https://doi.org/10.3390/molecules24142583
RethinkTHC
RethinkTHC Research Database. "Cannabidiol Treatment Might Promote Resilience to Cocaine an..." RTHC-01970. Retrieved from https://rethinkthc.com/research/calpe-lopez-2019-cannabidiol-treatment-might-promote
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.